Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Development and Validation of a Novel, Cost Effective UV Spectrophotometric Method for Simultaneous Estimation of Cilnidipine and Olmesartan


Affiliations
1 Department of Pharmaceutical Chemistry, P.E.S.’s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa,, India
     

   Subscribe/Renew Journal


Cilnidipine is a novel, dihydropyridine class of calcium-channel blocker. It prevents intracellular calcium influx and results in vasodilatation. Olmesartan medoxomil is a synthetic imidazole derivative prodrug and angiotensin II type blocker used to manage hypertension. The combination of cilnidipine and olmesartan medoxomil is used in the treatment of hypertension. Literature review revealed that there are many analytical methods involving HPLC and some using UV for estimation of the two drugs individually and in combination. UV spectrophotometric methods have the advantage of being simple, cost effective and rapid. Hence it was thought worthwhile to develop a simple, cost effective UV spectrophotometric method for simultaneous estimation of cilnidipine and olmesartan medoxomil employing the Absorption Correction principle. In this method, water: methanol (80:20,v/v) was used as the diluent. From the UV overlain spectra of both the drugs 257nm and 365nm were selected as wavelengths for analysis. The method was validated using the ICH guidelines. The linearity range was established from 10-100μg/ml (r2= 0.999) for cilnidipine and 10-80 μg/ml (r2= 0.998) for olmesartan medoxomil. The developed method was found to be accurate as % recovery at 80%, 100% and 120% levels were found to be within the acceptance criteria. The results for intra-day and inter-day precision were within acceptance limits of % RSD ˂ 2%. The method was found to be sensitive and robust. The developed method was applied in the estimation of Cilnidipine and Olmesartan in tablet dosage form and % assay was found to be 100.75% and 103.8% for the two drugs respectively. Hence the developed method can be employed as a simple, cost effective, quality control analytical method for simultaneous estimation of the two drugs in bulk and in combination.

Keywords

Cilnidipine, Olmesartan medoxomil, UV spectroscopy, Absorption Correction method, Validation, ICH guidelines.
Subscription Login to verify subscription
User
Notifications
Font Size


  • https://www.drugbank.ca/ (accessed on 23-01-2018)

  • https://pubchem.ncbi.nlm.nih.gov/ (accessed on 23-01-2018)

  • https://www.1mg.com/drugs/cilidin-o-20mg-10mg-tablet-342874 (accessed on 20-05-2018)

  • Ghelani NC. et al. Development and validation of spectrophotometric method for simultaneous estimation of olmesartan medoxomil and cilnidipine by simultaneous equation method. PharmaTutor Mag. 2014;2(6):160–66.

  • Thula KC, Patel DM, Maheshwari DG. Development and validation of first order derivative uv spectrophotometric method for simultaneous estimation of nebivolol and cilnidipine in pharmaceutical formulation. Int. J. Pharm. Sci. Rev. Res. 2015; 31(46): 243–47.

  • Sidhdhapara M. et al. Derivative spectrophotometric method for simultaneous determination of cilnidipine and olmesartan medoximil in tablet dosage form. Der. Pharma. Chem. 2014; 6(3): 175–78.

  • Sheth A, Patel CN, Shah N, Shah R. Simultaneous estimation of olmesartan medoxomil and indapamide by standard addition Uv spectrophotometric method in their combined dosage forms. Indian Drugs. 2017; 54(4): 80-86.

  • Sawale V, Dhabarde D, Kar Mahapatra D. Development and validation of UV spectrophotometric method for simultaneous estimation of olmesartan medoxomil and chlorthalidone in bulk and tablet. Eurasian. J. Anal. Chem. 2016; 12(1):55–66.

  • Minase AS, Dole MN, Sawant SD. Developement and validation of analytical method for simultaneous estimation of cilnidipine and olmesartan medoxomil in bulk and tablet dosage form by RP-HPLC. Int. J. Pharm. Pharm. Sci. 2014; 6(7): 508–11.

  • Rudrapal M. et al. Development and validation of RP-HPLC method for simultaneous estimation of olmesartan and hydrochlorothiazide in tablet dosage form. Orient. J. Chem. 2015; 31(2): 921–26.

  • Thakker NM. Et al. Development and validation of a stability indicating RP-HPLC method for simultaneous estimation of olmesartan medoxomil and metoprolol succinate in pharmaceutical dosage form. Pharm Methods. 2012; 3(2): 84-89.

  • Sawaikar L, Kapupara P. Development and validation of a Stability indicating RP-HPLC method for the estimation of chlorthalidone and cilnidipine in combined pharmaceutical dosage Form. Research J. Pharm. and Tech 2020; 13(5): 2376-2380.

  • Pai NR., Sawant SS. Development and validation of RP-HPLC method for estimation of olmesartan medoxomil in tablet dosage form. Research J. Pharm. and Tech. 2013; 6(11): 1279-1284.


Abstract Views: 125

PDF Views: 0




  • Development and Validation of a Novel, Cost Effective UV Spectrophotometric Method for Simultaneous Estimation of Cilnidipine and Olmesartan

Abstract Views: 125  |  PDF Views: 0

Authors

Sushmita Sawant
Department of Pharmaceutical Chemistry, P.E.S.’s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa,, India
Celina Nazareth
Department of Pharmaceutical Chemistry, P.E.S.’s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa,, India
Saumya Vernekar
Department of Pharmaceutical Chemistry, P.E.S.’s Rajaram and Tarabai Bandekar College of Pharmacy, Farmagudi, Goa,, India

Abstract


Cilnidipine is a novel, dihydropyridine class of calcium-channel blocker. It prevents intracellular calcium influx and results in vasodilatation. Olmesartan medoxomil is a synthetic imidazole derivative prodrug and angiotensin II type blocker used to manage hypertension. The combination of cilnidipine and olmesartan medoxomil is used in the treatment of hypertension. Literature review revealed that there are many analytical methods involving HPLC and some using UV for estimation of the two drugs individually and in combination. UV spectrophotometric methods have the advantage of being simple, cost effective and rapid. Hence it was thought worthwhile to develop a simple, cost effective UV spectrophotometric method for simultaneous estimation of cilnidipine and olmesartan medoxomil employing the Absorption Correction principle. In this method, water: methanol (80:20,v/v) was used as the diluent. From the UV overlain spectra of both the drugs 257nm and 365nm were selected as wavelengths for analysis. The method was validated using the ICH guidelines. The linearity range was established from 10-100μg/ml (r2= 0.999) for cilnidipine and 10-80 μg/ml (r2= 0.998) for olmesartan medoxomil. The developed method was found to be accurate as % recovery at 80%, 100% and 120% levels were found to be within the acceptance criteria. The results for intra-day and inter-day precision were within acceptance limits of % RSD ˂ 2%. The method was found to be sensitive and robust. The developed method was applied in the estimation of Cilnidipine and Olmesartan in tablet dosage form and % assay was found to be 100.75% and 103.8% for the two drugs respectively. Hence the developed method can be employed as a simple, cost effective, quality control analytical method for simultaneous estimation of the two drugs in bulk and in combination.

Keywords


Cilnidipine, Olmesartan medoxomil, UV spectroscopy, Absorption Correction method, Validation, ICH guidelines.

References